UBE Corporation’s Acquisition of LANXESS

Baker McKenzie advised UBE Corporation on the deal. UBE Corporation, a Japanese chemical company based in Tokyo, secured the acquisition of LANXESS’ Urethane Systems business (LANXESS...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

CureVac’s Collaboration with GSK

Baker McKenzie advised CureVac on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), restructured its existing collaboration...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here